Abstract:Parvovirus B19 (PB19) is a single-stranded DNA virus that belongs to the Erythrovirus genus within the Parvoviridae family. Clinical presentations associated with PB19 infection vary greatly, depending on the infected individual’s age and hematologic and immunologic status. The limited data available regarding consensus on screening algorithms and indications in donors and recipients prior to kidney transplantation makes diagnosis and management challenging. We presented 3 cases of pure red cell aplasia due to parvovirus B19 after kidney transplant. These patients were diagnosed with severe normocytic, normochromic anemia (hemoglobin below 60 g/L) in the 1st 6 months posttransplant. A complete anemia work-up revealed low reticulocyte count and was otherwise inconclusive. All patients were diagnosed with pure red cell aplasia due to parvovirus B19. Two patients improved after receiving intravenous immunoglobulin 2 gm/kg given over 4 doses. Unfortunately, they relapse after few weeks and required additional doses of intravenous immunoglobulin in conjugation with reduction of their immunosuppressive medication. The third patient improved after holding mycophenolate mofetil (MMF) and did not require intravenous immunoglobulin. Whereas PB19 infection is typically self-limiting and associated with positive IgM serology in immunocompetent hosts, these cases highlight the importance of considering PB19 infection in the differential diagnosis of persistent anemia in immunocompromised patients and the challenges in confirming the diagnosis. Intravenous immunoglobulin (IVIG) can be an effective treatment in immunocompromised patients with primary or relapsed PB19 infection in conjunction with minimizing immunosuppressive medication. Further research and consideration are required to determine appropriate and targeted screening in donors and recipients in the peritransplantation period.

Parvovirus B19 induced lupus-like syndrome with nephritis

Emerging lupus-like manifestations in acute parvovirus B19 infection

Human parvovirus B19-induced acute glomerulonephritis: a case report

Pericarditis and pleuritis associated with human parvovirus B19 infection in a systemic lupus erythematosus patient

Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?

Transient Systemic Lupus Erythematosus-like Syndrome Associated With Parvovirus B19 Infection: A Case Report

Case Report: Parvovirus B19 infection complicated by hemophagocytic lymphohistiocytosis in a heart-lung transplant patient

A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection

Parvovirus B19 infection associated with hemolytic anemia and cranial polyneuropathy

Parvovirus B19 and immune disorders

Does parvovirus infection have a role in systemic lupus erythematosus?

[Parvovirus B19 infections in adults]

Rheumatic manifestations and sequela of acute parvovirus B19 infection in hospitalized adult population

Parvovirus B19 in Rheumatic Diseases

High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease

Rapid progression to end-stage renal disease in a child with IgA-dominant infection-related glomerulonephritis associated with parvovirus B19

Erythema nodosum manifestation of Parvovirus B19-associated reactive arthritis

Infectious arthritis caused by human parvovirus B19: case report and literature review

[Review of correlation between human parvovirus B19 and autoimmune disease etiology]

Parvovirus B19 Infection due to over Immunosuppression in Kidney Transplant Recipients: Case Reports and Literature Review

Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses